ETBRIUN

Glaxo Group Limited

Application Filed: 2019-04-24
Trademark Application Details
Trademark Logo ETBRIUN

Mark For: ETBRIUN™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines. [all]

Status

2020-05-27 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number88399563
Mark Literal ElementsETBRIUN
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-03-03
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMerilee J. Arevalo
Attorney Docket Number82774749
Law Office AssignedN10
Employee NameTANNER, MICHAEL R

Timeline

2019-04-24Application Filed
2019-12-05Location: PUBLICATION AND ISSUE SECTION
2019-12-05Status: Live/Pending
2019-12-18Transaction Date
2020-01-07Published
2020-01-07Published for Opposition
2020-03-03Location: INTENT TO USE SECTION
2020-03-03Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six

Trademark Parties (Applicants & Owners)

Party: Glaxo Group Limited
Address980 Great West Road Brentford, Middlesex UNITED KINGDOM TW89GS
Legal Entity TypePrivate Company Limited By Shares (prc)
Legal Entity StateENGLAND

Documents

DrawingIMAGE/JPEG2019-04-24
TEAS Plus New ApplicationAPPLICATION/XML,IMAGE/JPEG2019-04-24
Notation to FileXML2019-06-10
XSearch Search SummaryXML2019-06-10
Offc Action OutgoingMULTI2019-06-13
Response to Office ActionAPPLICATION/XML,IMAGE/JPEG2019-10-30
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2019-10-31
TRAM Snapshot of App at Pub for OppostnMULTI2019-12-06
Notice of PublicationXML2019-12-18
Notification Of Notice of PublicationXML2019-12-18
OG Publication ConfirmationXML2020-01-07
Notice of AllowanceAPPLICATION/XML2020-03-03

Attorney of Record

Merilee J. Arevalo
GSK
LBP, 5.5A
5 MOORE DRIVE
RESEARCH TRIANGLE PARK NC 27709-3398

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

DescriptionDateProceeding Number
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-03-03
PUBLISHED FOR OPPOSITION2020-01-07
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-01-07
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-12-18
APPROVED FOR PUB - PRINCIPAL REGISTER2019-12-05
TEAS/EMAIL CORRESPONDENCE ENTERED2019-10-3088889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-10-30
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-10-3088889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-06-136325
NON-FINAL ACTION WRITTEN2019-06-1378480
NON-FINAL ACTION E-MAILED2019-06-136325
ASSIGNED TO EXAMINER2019-06-1078480
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-05-09
NEW APPLICATION ENTERED IN TRAM2019-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed